Laura Laemmle-Weidenfeld vigorously defends health care and life sciences clients against federal and state fraud enforcement actions and also draws on her experience to provide practical compliance advice on federal and state health care fraud and abuse issues. She has defended against numerous investigations and litigation brought by the Department of Justice (DOJ), various U.S. Attorneys offices, the Department of Health and Human Services Office of Inspector General (HHS-OIG), state attorneys general, and other state and federal agencies. Laura also helps clients navigate challenging compliance issues, including analyzing arrangements under the Stark Laws and Anti-Kickback Statute (AKS), conducting internal investigations, and preparing self-disclosures. She has been recognized as a leading health care lawyer by Chambers USA and Super Lawyers.
Laura has represented a broad spectrum of health care providers, including hospitals and health systems, home health care agencies, telehealth and other digital health entities, physician practices, clinical laboratories, post-acute care providers, and pharmacies, as well as pharmaceutical and medical device manufacturers.
Earlier in her career, Laura served as a trial attorney in the Frauds Section of DOJ's Civil Division, where she investigated and litigated health care fraud matters brought under the False Claims Act (FCA) and its whistleblower (or qui tam) provisions.
An active member of the American Health Law Association (AHLA) (chair, Fraud and Abuse Practice Group, 2014-2017), Laura frequently speaks and writes on health care fraud issues. She is the author of Legal Issues in Health Care Fraud and Abuse, Fifth Edition, published by AHLA in 2020.
The following represents experience acquired prior to joining Jones Day.
On behalf of multiple affiliated not-for-profit skilled nursing facilities, successfully resolved a False Claims Act quality-of-care investigation by negotiating a False Claims Act settlement with the Department of Justice on an ability-to-pay basis and negotiating a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General, in an investigation conducted by the U.S. Attorney's Office for the District of Maryland and the State of Maryland Office of the Attorney General.
Successfully represented a hospital in an investigation by the U.S. Department of Health and Human Services Office of Inspector General, which resulted in that office's declination of the matter.
Successfully represented a national home health care provider in a parallel civil False Claims Act and criminal investigation led by the U.S. Attorney's Office in Newark, New Jersey and negotiated a global resolution in which the company entered into a Deferred Prosecution Agreement and civil settlements with the United States and more than 30 states, as well as a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General.
Filed successful motion in the Eastern District of Michigan to dismiss a complaint alleging False Claims Act violations by a dialysis provider in connection with the quality of care provided to Medicare and Medicaid patients.
Filed successful motion in the Middle District of Florida to dismiss a complaint alleging False Claims Act violations in connection with marketing practices allegedly undertaken by a for-profit provider of higher education.
Filed successful motion in federal district court in the District of Columbia to dismiss a complaint against small business subcontractor alleging False Claims Act violations relating to contract for provision of IT services to the United States Customs and Immigration Services.
On behalf of individual dermatologist, assisted in successfully negotiating a False Claims Act resolution in a matter involving alleged violations of the Anti-Kickback Statute.
Filed successful motions in the Western District of Wisconsin to dismiss a government complaint alleging False Claims Act violations by a pharmacy chain in connection with Medicaid billings for prescription drugs provided to consumers with primary private insurance coverage.
Represented an individual consultant who provided FDA-related assistance to a start-up medical device manufacturer, in an investigation by the U.S. Attorney's Office in Boston, Massachusetts, under the False Claims Act and the Federal Food, Drug, and Cosmetic Act, which the U.S. Attorney's Office ultimately declined to pursue.
On behalf of a well-known nationwide DME (durable medical equipment) provider, successfully resolved False Claims Act litigation relating to marketing practices by negotiating a civil settlement with the Department of Justice and a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General.
Successfully defended a national home health care provider against a criminal investigation by a state attorney general's office, ultimately obtaining a formal declination of the matter, which related to Medicaid billing concerns.
Federal Court of Appeals Emphasizes Only Defendants Who Act "Knowingly" Can Be Liable Under the False Claims Act
How Not to Go Down in Flames with Your Client in Fraud Matters: Compliance with the Ethical Rules is Not Enough!, coauthor, American Health Lawyers Association/Health Care Compliance Association Fraud and Compliance Institute Course book
Navigating the Complexities of Health Care Law Enforcement and Compliance, Inside the Minds: Health Care Law Enforcement and Compliance, 2013 ed., Aspoatore Books
The Intersection of the Stark Law and Medicaid Claims: Catching Providers in a Legal Quagmire, coauthor, AHLA Connections
Coronia: The Anticipated Effect on Off-Label Cases, American Health Lawyers Association Institute on Medicare and Medicaid Payment Issues coursebook
February 20, 2013
Negotiating a Criminal Settlement in a Health Care Case, coauthor, BNA Health Care Fraud Report
Manufacturer Liability Under the False Claims Act Based on Violations of Other Statutes: No Relief in Sight, Practising Law Institute, Health Care and Life Sciences Law 2012 conference coursebook
The Intersection Between the Civil False Claims Act and the 60-Day Overpayment Rule, coauthor, American Health Lawyers 2012 Annual Meeting coursebook
Supreme Court Continues Status Quo on FCA ‘Implied Certification’ Theory, American Health Lawyers Association Fraud and Abuse Newsletter, Vol. I, Issue 2
In-House Counsel Beware: The False Claims Act May Impact Your Business, coauthor, ACC Docket
- October 13, 2020
Life Sciences 2020: Navigating Legal Challenges in Drug and Device Industries
- September 30-October 2, 2020
Fraud and Compliance Forum, AHLA
- December 1, 2019
PLI's Hot Topics in Health Care Law
- October 10, 2019
Practising Law Institute, Life Sciences: Navigating Legal Challenges in Drug and Device Industries
- September 25-27, 2019
Fraud and Compliance Forum, AHLA
- March 20-22, 2019
Institute on Medicare and Medicaid Payment Issues
Hot Topics in Health Care Law 2018, Enforcement Trends in Health Care Law -- Overview and Lessons Learned in 2018
- September 26-28, 2018
Fraud and Compliance Forum
- May 22-23, 2018
American Conference Institute’s (ACI) Life Sciences & Healthcare Qui Tam and False Claims Summit
- March 21-23, 2018
Institute on Medicare and Medicard Payment Issues, AHLA
- December 14, 2017
PLI's Health Care Law Institute 2017
- October 4-6, 2017
Fraud and Compliance Forum, AHLA
- June 26-28, 2017
Modern Ethics Rules for Attorneys Managing Internal and Government Investigations and Litigation, panelist, AHLA Annual Meeting
- April 4, 2017
Fraud and Abuse Advanced Enforcement, Part I: Advanced Tactics and Strategies for Handling FCA Actions (Advanced)
- March 29-31, 2017
Hot Topics in Health Care Fraud and Abuse, panelist, AHLA Medicare and Medicaid Payment Institute
- March 26, 2017
Anatomy of a False Claims Act Case, panelist, Health Care Compliance Association's 21st Annual Compliance Institute
- December 13, 2016
PLI's Health Care Law Institute 2016: Emerging Challenges and Trends in Reimbursement, Enforcement, Compliance and other Hot Topics
- November 2, 2016
PLI's Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries
- October 25, 2016
Negotiating and Surviving a Corporate Integrity Agreement, panelist, Health Care Compliance Association's Healthcare Enforcement Compliance Institute
- October 6-7, 2016
The Lifecycle of a CIA: How to Get Started, Survive and Thrive, panelist, AHLA Fraud and Compliance Forum
- September 29, 2016
Successfully Mediating Healthcare False Claims Act Cases, panelist
- May 4, 2016
Compliance in the Precision Medicine Era: Legal Considerations for the Contemporary Life Sciences Industry
- April 17, 2016
20th Annual Compliance Institute, Health Care Compliance Association
- April 13-14, 2016
Institute on Medicare and Medicaid Payment Issues, AHLA
- January 21, 2016
The Year in Review - What Recent Cases Reveal about Future False Claims Act Litigation, panelist, American Conference Institute's 3rd Annual Executive Forum on False Claims & Qui Tam Enforcement
- November 11, 2015
Compliance Programs and Investigations, panelist, Health Care Law Institute 2015: Emerging Challenges and Trends in Reimbursement, Enforcement and Other Hot Topics
- October 28, 2015
Effective Compliance Programs and Investigations: A Hypothetical, panelist, PLI's Life Sciences 2015: Navigating Legal Challenges in the Drug and Device Industries
- October 25, 2015
Anatomy of False Claims Act Case: Investigation, Negotiation, Resolution, panelist, Health Care Compliance Association's 2015 Healthcare Enforcement Compliance Institute
- September 28-29, 2015
Managed Care: Fraud and Abuse's New Frontier. panelist, American Health Lawyer's Association Fraud and Compliance Forum
- May 15, 2015
Anatomy of an Internal Investigation and its Aftermath, panelist, Health Care Compliance Association Regional Conference
- May 13-15, 2015
Litigating False Claims Act Cases, moderator, American Bar Association's 25th Annual National Institute on Health Care Fraud
- March 25-27, 2015
Recent Developments in Fraud and Abuse Enforcement, moderator, American Health Lawyers Association's Institute on Medicare and Medicaid Payment Issues
- January 21-22, 2015
Inside the Most Significant Legal Issues Arising from False Claims Act Litigation, panelist, American Conference Institute's 2nd Advanced Forum on False Claims Act and Qui Tam Enforcement
- January 16, 2015
Legal Perspectives Essential to Reimbursement, American Telemedicine Association
- October 24, 2014
Effective Compliance Programs and Investigations: A Hypothetical, Practising Law Institute's Health Care and Life Sciences Law 2014
- October 6-7, 2014
Tips on Negotiating and Then Living Under a CIA, panelist, American Health Lawyers Association Fraud and Compliance Forum
Speaking Engagements Prior to Jones Day
March 26-27, 2014
Recent Developments in Fraud and Abuse Enforcement, panelist, American Health Lawyers Association’s Institute on Medicare and Medicaid Payment Issues
January 28, 2014
FCA and Qui Tam Settlement Strategy Session: The Finer Points for Determining When to Engage in Settlement Discussions, and How to Negotiate with Federal and State Authorities, panelist, ACI Executive Forum on False Claims and Qui Tam Enforcement
New York, New York
October 4, 2013
Enforcement Trends, panelist, Practising Law Institute’s Health Care and Life Sciences Law 2013
New York, NY
September 30-October 1, 2013
Legal Ethics: How Not to Go Down in Flames with Your Client, panelist, American Health Lawyers Association/Health Care Compliance Association’s Fraud and Compliance Forum
July 1-3, 2013
Fraud and Abuse: Hot Topics, panelist, American Health Lawyers Association’s Annual Meeting
San Diego, CA
April 21-24, 2013
Navigating the OIG’s Self-Disclosure Protocol, panelist, Health Care Compliance Association’s 17th Annual Compliance Institute
National Harbor, MD
April 18-19, 2013
Litigating Under the False Claims Act, panelist, CLE International’s False Claims Act and Qui Tam Conference
San Francisco, CA
March 20-22, 2013
Evolving Fraud and Abuse Issues, panelist, American Health Lawyers Association’s Institute on Medicare and Medicaid Payment Issues
June 26-27, 2012
Fraud and Abuse Year in Review: Hot Topics, panelist, American Health Lawyers Association’s Annual Meeting
June 6-8, 2012
Investigation of a False Claims Act Case, panelist, American Bar Association’s Ninth National Institute on the Civil False Claims Act and Qui Tam Enforcement
September 27, 2011
Settling False Claims Act Cases in the Healthcare Fraud and Enforcement World: Tips and Traps for Providers and Payors, panelist, American Health Lawyers Association’s Fraud and Compliance Forum
- Georgetown University (J.D. 1996); Northwestern University (B.A. and B.M. 1991)
- District of Columbia, Virginia, and U.S. District Courts for the District of Columbia, Northern District of Illinois, Eastern District of Michigan, Western District of Wisconsin, and Eastern and Western Districts of Virginia
- Trial Attorney, Frauds Section, Civil Division, U.S. Department of Justice (2000-2005)
Chambers USA (2020-2021)
Super Lawyers (2016-2022)
Two special commendations awarded by the Department of Justice Civil Division for her role in a precedent-setting matter against a major pharmaceutical company (2004) and for her role in a landmark case against a national hospital chain (2003)
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice